Back to today’s briefing

Story perspectives

Breakthrough: Drug Alleviates Sjögren’s Symptoms in Mice

1/7/2025

25 2

Summary

Story summary

Dysfunctional regulatory T-cells (Tregs) play a significant role in Sjögren’s disease, leading to uncomfortable symptoms like dry mouth and eyes. Excitingly, blocking interferon-gamma with baricitinib showed promise in alleviating these symptoms in mice. This groundbreaking research connects Treg dysfunction to inflammation, opening new doors for potential treatments in humans battling Sjögren’s disease.

1 of 1

Story summary

Dysfunctional regulatory T-cells (Tregs) play a significant role in Sjögren’s disease, leading to uncomfortable symptoms like dry mouth and eyes. Excitingly, blocking interferon-gamma with baricitinib showed promise in alleviating these symptoms in mice. This groundbreaking research connects Treg dysfunction to inflammation, opening new doors for potential treatments in humans battling Sjögren’s disease.